Jerome H. Kim appointed as Director General of IVI


September 29, 2014

The International Vaccine Institute (IVI), a Seoul-based non-profit international organization devoted to research in vaccine development and delivery for the developing world, announced the appointment of Jerome H. Kim, M.D., as the organization’s Director General, effective early 2015.

“Jerome’s scientific knowledge, technical expertise, and organizational and leadership skills make him an ideal fit for the position,” said Prof. Adel A. Mahmoud, Chair of IVI’s Board of Trustees. “With his distinguished track record in vaccine research & development and passionate commitment to vaccines, he will bring strong scientific leadership and management of a dynamic international organization.”

“I am honored by the opportunity to join IVI, and I look forward to working with the IVI team, partners, and donors,” said Dr. Kim, “IVI is a very unique organization. Its breadth in vaccinology spans research & development, epidemiology, technology transfer, policy and access. Together, we will improve the health and wellbeing of the world’s poorest populations through fulfilling IVI’s mission – to discover, develop, and deliver safe, effective and affordable vaccines for developing nations.”

A medical doctor by training and a colonel in the United States Army Medical Corps, Dr. Kim is a recognized leader in HIV research and HIV vaccine development. He was named one of “The 50 Most Influential People in Vaccines” in 2014 by the vaccine industry organization Vaccine Nation. Dr. Kim was the Principal Deputy and Chief of the Laboratory of Molecular Virology and Pathogenesis at the U.S. Military HIV Research Program (MHRP) and the U.S. Army’s Project Manager for the HIV Vaccines and Advanced Concepts Evaluation and Staging.

He was the U.S. Army lead for the Phase III HIV vaccine trial (RV144), which was the first to show that an HIV vaccine could protect against infection, as well as subsequent studies that identified laboratory correlates and HIV sequence changes associated with vaccination. His research interests include HIV molecular epidemiology, host genetics, and HIV vaccine development.  He has authored over 140 publications.

Dr. Kim is a Professor of Medicine at the Uniformed Services University of the Health Sciences and is a Fellow of the American College of Physicians and the Infectious Diseases Society of America. He received his M.D. from the Yale University School of Medicine, and completed his training in Internal Medicine and fellowship in Infectious Diseases at Duke University Medical Center.

Leave a Reply

Your email address will not be published. Required fields are marked *